TB diagnosis machine shows ground-breaking results

04 November 2013 | Story by Newsroom

Prof Keertan DhedaProf Keertan Dheda

The first randomised trial to measure the impact of the rapid Xpert MTB/RIF test for tuberculosis (TB) in a real-life clinical setting finds that it can be accurately performed by a non-specialist with minimal training, improves same-day diagnosis and time to starting treatment, and increases the number of people who start treatment after testing positive on day 1 by 50%, compared with conventional TB diagnostics.

"Despite already being rolled-out in many countries, our study is the first to look at the feasibility of the Xpert test in a real-life clinical setting in southern Africa", explains study leader Professor Keertan Dheda from the Department of Medicine, University of Cape Town in South Africa in The Lancet.

Look out for the upcoming November edition of the Monday Monthly to read the full feature.

Creative Commons License This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Please view the republishing articles page for more information.